deoxyhypusine has been researched along with Alloxan Diabetes in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Imam, S; Jaume, JC; Mirmira, RG | 1 |
1 other study(ies) available for deoxyhypusine and Alloxan Diabetes
Article | Year |
---|---|
Eukaryotic translation initiation factor 5A inhibition alters physiopathology and immune responses in a "humanized" transgenic mouse model of type 1 diabetes.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Enzyme Inhibitors; Eukaryotic Translation Initiation Factor 5A; Female; Glutamate Decarboxylase; Guanine; HLA-DQ alpha-Chains; HLA-DQ beta-Chains; Humans; Immunity, Innate; Lysine; Mice; Mice, Transgenic; Oxidoreductases Acting on CH-NH Group Donors; Peptide Initiation Factors; RNA-Binding Proteins | 2014 |